| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | 1 | — | — | — | — | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2026 | 0.40 |
—
—
—
|
| 2025 | 0.32 |
—
—
—
—
|
| 2024 | 0.32 |
—
—
—
—
|
| 2023 | 0.32 |
—
—
—
—
|
| 2022 | 0.32 |
—
—
—
—
|
| 2021 | 0.32 |
—
—
—
—
|
| 2020 | 0.32 |
—
—
—
—
|
| 2019 | 0.32 |
—
—
—
—
|
| 2018 | 0.24 |
—
—
—
—
|
| 2017 | 0.16 |
—
—
—
—
|
| 2016 | 0.16 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 58.47 | 103.00 | 78.12 | 64.22 |
| Receivables | 105.61 | 203.63 | 205.38 | 220.37 |
| Inventory | 97.96 | 275.55 | 254.12 | 276.40 |
| Other | 11.56 | 5.68 | 3.76 | 3.85 |
| 273.60 | 611.27 | 573.78 | 602.28 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 74.37 | 124.40 | 131.31 | 127.03 |
| ST’ Debt | 2.37 | 25.75 | 27.56 | 26.55 |
| Other | 50.32 | — | — | — |
| 134.66 | 272.87 | 281.55 | 269.91 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Jan | Apr | Jul | Oct | Year | |
|---|---|---|---|---|---|
| ’26 | 409.09 | 462.37 | 501.85 | — |
—
|
| ’25 | 400.04 | 452.48 | 495.27 | 489.85 |
1,837.64
|
| ’24 | 239.16 | 266.20 | 280.35 | 492.16 |
1,277.86
|
| ’23 | 261.92 | 273.54 | 299.64 | 295.49 |
1,130.58
|
| ’22 | 267.04 | 322.89 | 324.04 | 307.53 |
1,221.50
|
| ’21 | 230.15 | 270.36 | 279.88 | 291.77 |
1,072.15
|
| ’20 | 196.60 | 187.48 | 212.10 | 255.41 |
851.57
|
| Jan | Apr | Jul | Oct | Year | |
|---|---|---|---|---|---|
| ’26 | (20.21) | 18.92 | 58.55 | — |
—
|
| ’25 | (12.51) | 28.50 | 60.66 | 88.25 |
164.90
|
| ’24 | 3.85 | 33.09 | 46.39 | 5.48 |
88.81
|
| ’23 | 3.14 | 35.33 | 64.10 | 44.49 |
147.05
|
| ’22 | (21.65) | 19.77 | 51.74 | 48.11 |
97.97
|
| ’21 | (3.39) | 32.36 | 18.48 | 31.15 |
78.59
|
| ’20 | (3.66) | 6.13 | 45.09 | 53.24 |
100.80
|
| Jan | Apr | Jul | Oct | Year | |
|---|---|---|---|---|---|
| ’26 | (31.45) | 7.87 | 47.84 | — |
—
|
| ’25 | (23.96) | 13.78 | 46.19 | 66.88 |
102.89
|
| ’24 | (5.69) | 25.55 | 40.16 | 6.76 |
66.77
|
| ’23 | (4.35) | 27.84 | 56.81 | 29.62 |
109.92
|
| ’22 | (29.01) | 13.38 | 46.13 | 34.50 |
65.00
|
| ’21 | (8.58) | 29.40 | 13.74 | 25.31 |
59.88
|
| ’20 | (12.97) | (0.84) | 40.83 | 48.55 |
75.57
|
| Jan | Apr | Jul | Oct | Year | |
|---|---|---|---|---|---|
| ’26 | (0.09) | 0.07 | 0.58 | — |
—
|
| ’25 | (0.32) | 0.44 | (6.04) | 0.43 |
(5.43)
|
| ’24 | 0.19 | 0.46 | 0.77 | (0.30) |
0.90
|
| ’23 | 0.06 | 0.65 | 0.96 | 0.83 |
2.50
|
| ’22 | 0.34 | 0.80 | 0.78 | 0.75 |
2.66
|
| ’21 | 0.24 | 0.43 | 0.41 | 0.62 |
1.70
|
| ’20 | 0.00 | 0.17 | 0.33 | 0.68 |
1.17
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 18.00 | 18.71 | 22.92 | 11.04 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 25.94 | 35.03 | 39.31 | 24.79 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,875 | 3,792 | 7,068 | 7,071 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.32 | 0.30 | 0.18 | 0.26 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,221.50 | 1,130.58 | 1,277.86 | 1,837.64 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 21.98% | 24.55% | 23.92% | 27.17% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 109.76 | 97.05 | 42.08 | (242.59) | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.99% | 8.58% | 3.29% | (13.20%) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 88.34 | 82.50 | 33.06 | (250.81) | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 40.11 | 42.87 | 60.33 | 405.73 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 36.96 | 34.45 | 35.09 | 39.80 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 2.67 | 2.51 | 0.91 | (5.43) | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.96 | 4.48 | 2.44 | 3.57 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.00) | (1.13) | (0.61) | (1.34) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.97 | 3.35 | 1.83 | 2.23 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.07 | 16.62 | 27.76 | 15.73 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.05 | 32.82 | 36.42 | 46.17 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 8.27 | 10.65 | 25.72 | 0.00 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.60 | 0.78 | 0.83 | 0.36 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | 1.58 | 1.62 | 1.05 | 0.90 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.58 | 0.79 | 1.34 | 0.69 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.89 | 8.11 | 25.73 | 12.35 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 97.97 | 147.05 | 88.81 | 164.90 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (32.96) | (37.14) | (22.04) | (62.01) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 65.00 | 109.92 | 66.77 | 102.89 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 140.82 | 138.94 | 338.40 | 292.23 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 30.67 | 68.80 | 762.94 | 692.83 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (24.42) | 10.33 | 659.95 | 614.71 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 464.84 | 545.55 | 1,010.75 | 726.18 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.25% | 10.61% | 2.10% | (11.70%) | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.79% | 12.45% | 2.05% | (9.04%) | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.97% | 16.33% | 4.25% | (28.88%) | — | — | — |
ROE
|
Quanex Building Products (NX) has masked cyclical vulnerabilities with a decade of revenue growth and profitability peaks through 2022, but a dramatic 2024 pivot—exploding debt 1,007% to $763 million, doubled headcount, and 27% share dilution—signals acquisition overreach that could trap investors in a leverage nightmare. Forecasts paint a brutal 2025 trough with a $243 million EBT loss, -13% margins, and EPS plunging to -$5.43, shredding ROE and ROIC amid persistent housing headwinds like high rates and cooling starts. While gross margins hold firm and FCF remains a modest anchor, the balance sheet strain screams caution, especially as insiders dump shares despite analyst targets dangling 13-36% upside.
This isn’t just M&A indigestion; it’s a classic cyclical trap where optimistic revenue explosions to $1.84 billion in 2025 assume flawless housing rebounds that history routinely crushes. Elevated valuations (25x PE trailing) and bearish insider activity undermine the rosy 2026-2027 recovery narrative, leaving scant margin of safety if debt covenants crack or tariffs bite. Contrarians should eye NX as a high-stakes bet on execution amid industry consolidation—dive into the full analysis for the metrics exposing why patience might demand passing altogether.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.